MA43826A - Inhibiteurs substitués de ménine-mll et méthodes d'utilisation - Google Patents
Inhibiteurs substitués de ménine-mll et méthodes d'utilisationInfo
- Publication number
- MA43826A MA43826A MA043826A MA43826A MA43826A MA 43826 A MA43826 A MA 43826A MA 043826 A MA043826 A MA 043826A MA 43826 A MA43826 A MA 43826A MA 43826 A MA43826 A MA 43826A
- Authority
- MA
- Morocco
- Prior art keywords
- menine
- mll
- substitute
- inhibitors
- methods
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662309372P | 2016-03-16 | 2016-03-16 | |
PCT/US2017/022564 WO2017161028A1 (fr) | 2016-03-16 | 2017-03-15 | Inhibiteurs substitués de ménine-mll et méthodes d'utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
MA43826A true MA43826A (fr) | 2018-11-28 |
MA43826B1 MA43826B1 (fr) | 2023-07-31 |
Family
ID=62683542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA43826A MA43826B1 (fr) | 2016-03-16 | 2017-03-15 | Composés thiéno[2,3-d]pyrimidiniques substitués en tant qu'inhibiteurs de ménine-mll et méthodes d'utilisation |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR107891A1 (fr) |
MA (1) | MA43826B1 (fr) |
-
2017
- 2017-03-15 AR ARP170100642A patent/AR107891A1/es unknown
- 2017-03-15 MA MA43826A patent/MA43826B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
MA43826B1 (fr) | 2023-07-31 |
AR107891A1 (es) | 2018-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA43823A (fr) | Inhibiteurs bicycliques pontés de ménine-mll et méthodes d'utilisation | |
MA42925A (fr) | Anticorps anti-tigit et méthodes d'utilisation | |
HK1259232A1 (zh) | Menin-mll的取代抑制劑及其使用方法 | |
MA44990A (fr) | Polythérapies d'inhibiteurs de hdac et d'inhibiteurs de pd-l1 | |
MA46481A (fr) | Compositions d'oligonucléotides et méthodes associées | |
MA43387A (fr) | Anticorps anti-gitr et leurs méthodes d'utilisation | |
MA49403A (fr) | Compositions de pde5 et méthodes d'immunothérapie | |
MA42243A (fr) | Anticorps de facteur xi et méthodes d'utilisation | |
MA44991A (fr) | Polythérapies d'inhibiteurs de hdac et d'inhibiteurs de pd-1 | |
DK3368069T3 (da) | Anvendelse af myostatininhibitorer og kombinationsterapier | |
MA43816A (fr) | Protéines de liaison inductibles et méthodes d'utilisation | |
MA45123A (fr) | Anticorps anti-tim-3 et leurs méthodes d'utilisation | |
MA48579A (fr) | Anticorps anti-pd1 et méthodes d'utilisation de ceux-ci | |
MA44955A (fr) | Anticorps anti-tau et leurs méthodes d'utilisation | |
MA42542A (fr) | Molécules se liant à pd-1 et méthodes d'utilisation correspondantes | |
DK3259253T3 (da) | Sulfonylureaer og relaterede forbindelser og brug af samme | |
IL267291A (en) | Actonucleotidase inhibitors and methods of using them | |
MA43284A (fr) | Composés et leurs méthodes d'utilisation | |
MA48595A (fr) | Anticorps anti-tau et leurs méthodes d'utilisation | |
MA49715A (fr) | Oligomères et conjugués d'oligomères | |
MA43385A (fr) | Nouveaux anticorps anti-claudine et méthodes d'utilisation | |
MA44526A (fr) | Oxystérols et leurs méthodes d'utilisation | |
MA46422A (fr) | Oligonucléotides modifiés et méthodes d'utilisation | |
MA41642A (fr) | Variants de protoxine ii et méthodes d'utilisation | |
MA42118A (fr) | Benzamides substitués et leurs méthodes d'utilisation |